Related Experiment Video
Updated: May 19, 2026
Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
Published on: June 16, 2022
Use of TYRX antibacterial envelope in inflatable penile prosthesis surgery: a prospective pilot study
Jack T Rifkin1, Julia A Baran1, Brian H Im1
1Department of Urology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, United States.
Background:
Infection remains a major concern in inflatable penile prosthesis (IPP) surgery. Medtronic's TYRX Absorbable Antibacterial Envelope is a polypropylene mesh pocket delivering minocycline and rifampin for 7 days and fully absorbing in 9 weeks. It is currently FDA-approved for use with cardiac pacemakers and neuromodulation devices. There is no indication for use in IPP surgeries, particularly for enveloping the scrotal pump during implantation.
Aim:
This pilot study evaluates the feasibility, safety, and early patient-reported outcomes with the use of the absorbable antibacterial envelope during IPP surgery.
Methods:
Fifteen men who underwent primary or revision IPP placement by a single high-volume surgeon were enrolled between January and May 2025. Demographic and comorbidity data were collected. IPP pumps were placed in the absorbable antibacterial envelope and then positioned into a sub-dartos pouch; no other changes to standard-of-care surgical placement were made.
Outcomes:
The primary endpoint was the patient's ability to locate and operate the pump within 6 weeks after surgery. Secondary endpoints included infection and mechanical malfunction within 6 months after surgery.
Results:
Fifteen patients were enrolled and followed for up to 6 months postoperatively. Patients were able to utilize the pump by the 6-week visit. More than half of participants were overall "very" or "extremely" satisfied (8/15, 53%) and confident (12/15, 80%) with the inflation and deflation process. No patient experienced infection or malfunction. One patient on anticoagulation and hemodialysis developed a scrotal hematoma, which resolved conservatively.
Clinical Implications:
These findings support continued evaluation of the absorbable antibacterial envelope as an adjunctive infection-prevention strategy in prosthetic urology.
Strengths & Limitations:
To our knowledge, this is the first study to evaluate the absorbable antibacterial envelope in IPP surgery. Limitations include its single-center design, small sample size, short duration of follow-up, and lack of a control group for patient-reported outcome comparisons. This study was underpowered to evaluate the antibacterial envelope's efficacy or long-term infection outcomes.
Conclusion:
Use of the absorbable antibacterial envelope in IPP surgery appears feasible and safe, with patients being able to utilize the pump postoperatively. No infection or mechanical malfunctions were encountered.
Insights
This pilot study found the absorbable antibacterial envelope feasible and safe for inflatable penile prosthesis (IPP) surgery. Patients could operate the pump, with no infections or malfunctions reported in this initial evaluation.
Area of Science:
- Urology
- Surgical Innovation
- Infection Prevention
Background:
- Infection is a significant risk in inflatable penile prosthesis (IPP) surgery.
- The TYRX Absorbable Antibacterial Envelope delivers antibiotics and is FDA-approved for other implantable devices.
- Its use in IPP surgery, specifically for the scrotal pump, is not currently indicated.
Purpose of the Study:
- To assess the feasibility and safety of using the absorbable antibacterial envelope in IPP procedures.
- To evaluate early patient-reported outcomes, including pump operability and satisfaction.
- To identify any adverse events associated with this adjunctive approach.
Main Methods:
- A pilot study involving 15 men undergoing IPP placement by a single surgeon.
- The IPP pump was enclosed in the antibacterial envelope before placement in a sub-dartos pouch.
- Standard surgical techniques were otherwise maintained.
Main Results:
- All 15 patients could locate and operate the pump by 6 weeks post-surgery.
- Over half reported high satisfaction (53%) and confidence (80%) with pump function.
- No infections or mechanical malfunctions occurred; one patient developed a scrotal hematoma that resolved conservatively.
Conclusions:
- The absorbable antibacterial envelope appears feasible and safe for IPP surgery.
- It allows for normal pump utilization and does not introduce immediate complications.
- Further investigation is warranted to confirm its efficacy as an infection-prevention strategy in prosthetic urology.
